Search results
Could psychedelic therapy be the next frontier for mental health care in California?
Sacramento Bee via Yahoo News· 10 months agoPsychdelics such as LSD, ketamine and psilocybin, used by therapists to assist in the treatment of...
$15 million grant allows for further trials of UC Davis Health Spina Bifida treatment
KTXL via Yahoo News· 7 months ago(FOX40.COM) — A UC Davis Health research team has been awarded $15 million to continue their...
Dr. Robert Lufkin and Dr. Stephen Sideroff Join Forces on Their "Path of Longevity Summit" April...
NewMediaWire via Yahoo Finance· 1 year agoReverse Inflammaging Summit: Beverly Hills, CA - (NewMediaWire) - February 28, 2023 - ANNOUNCED...
Regenerative medicine effort generates interest in Manchester growth
Tribune via AOL· 1 month agoMay 10—One company in Manchester's Millyard is working on a retinal patch to help cure macular degeneration affecting people's vision. Another Millyard firm is developing a tissue graft that ...
Lack of diversity in clinical trials is leaving women and patients of color behind and harming the...
The Conversation via Yahoo News· 1 year agoMost clinical trials overrepresent young white males. Andresr/Digital Vision via Getty ImagesIts a...
A salty diet may increase eczema in adults, study finds
Washington Post via Yahoo News· 1 week agoAdults who eat a salty diet appear to have a higher risk for eczema, according to a study by...
OpenAI’s Sam Altman is the latest tech entrepreneur making a play to extend the human lifespan. Here...
Business Insider via Yahoo Finance· 1 year agoSam Altman, CEO of ChatGPT maker OpenAI, appears to be the latest tech entrepreneur dabbling in...
The tech billionaires trying to hack longevity and live forever
Business Insider via Yahoo Finance· 6 months agoFrom Sam Altman (from top left, clockwise) to Peter Thiel, Mark Zuckerberg, Jeff Bezos, and Sergey...
Fate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 4 months agoRevenue: Reported $1.7 million for the fourth quarter of 2023. Operating Expenses: GAAP operating expenses were $49.8 million for the fourth quarter. Net Loss: Recorded a net loss of $44.1 million ...
Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges
GuruFocus.com via Yahoo Finance· 6 months agoAvid Bioservices Inc (NASDAQ:CDMO) reports a second-quarter revenue of $25.4 million, a decrease...